Aerosol delivery of kinase-deficient Akt1 attenuates Clara cell injury induced by naphthalene in the lungs of dual luciferase mice

Journal of Veterinary Science

Volumn 12, Issue 4, 2011, Pages 309-317

  Arash, Minai Tehrani ^a   Park, Young Chan ^a   Hwang, Soon Kyung ^a   Kwon, Jung Taek ^a   Chang, Seung Hee ^a   Park, Sung Jin ^a   Yu, Kyeong Nam ^a   Kim, Ji Eun ^a,b   Shin, Ji Young ^a   Kim, Ji Hye ^a,b   Kang, Bitna ^a   Hong, Seong Ho ^a   Cho, Myung Haing ^a,b  

^a Seoul National University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Aerosol delivery; Akt1; Clara cell; ERK; Luciferase activity; Naphthalene

Indexed keywords

AKT1 PROTEIN, MOUSE; LUCIFERASE; NAPHTHALENE; NAPHTHALENE DERIVATIVE; PROTEIN KINASE B;

AEROSOL; ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; GENE EXPRESSION REGULATION; GENE SILENCING; GENE THERAPY; GENE TRANSFER; GENETICS; INHALATIONAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG DISEASE; MALE; METABOLISM; METHODOLOGY; MOUSE; REPORTER GENE; TRANSGENIC MOUSE;

ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, REPORTER; INJECTIONS, INTRAPERITONEAL; LUCIFERASES; LUNG DISEASES; MALE; MICE; MICE, TRANSGENIC; NAPHTHALENES; PROTO-ONCOGENE PROTEINS C-AKT;

MUS;

EID: 84860748232     PISSN: 1229845X     EISSN: None     Source Type: Journal    
DOI: 10.4142/jvs.2011.12.4.309     Document Type: Article

References (52)

1. Avruch J, Belham C, Weng Q, Hara K, Yonezawa K. The p70 S6 kinase integrates nutrient and growth signals to control translational capacity. Prog Mol Subcell Biol 2001, 26, 115-154.
2. Bellacosa A, Testa JR, Staal SP, Tsichlis PN. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 1991, 254, 274-277.
3. Chang RCC, Yu MS, Lai CSW. Significance of molecular signaling for protein translation control in neurodegenerative diseases. Neurosignals 2007, 15, 249-258.
4. Cheng JQ, Lindsley CW, Cheng GZ, Yang H, Nicosia SV. The Akt/PKB pathway: molecular target for cancer drug discovery. Oncogene 2005, 24, 7482-7492.
5. Commander H. Biotechnology industry responds to gene therapy death. Nat Med 2000, 6, 118.
6. Créancier L, Mercier P, Prats AC, Morello D. c-myc Internal ribosome entry site activity is developmentally controlled and subjected to a strong translational repression in adult transgenic mice. Mol Cell Biol 2001, 21, 1833-1840.
7. Diodovich C, Malerba I, Bowe G, Acquati F, Bianchi MG, Taramelli R, Parent-Massin D, Gribaldo L. Naphthalene exposure: effects on gene expression and proliferation in human cord blood cells. J Biochem Mol Toxicol 2003, 17, 286-294.
8. Dolivet G, Merlin JL, Barberi-Heyob M, Ramacci C, Erbacher P, Parache RM, Behr JP, Guillemin F. In vivo growth inhibitory effect of iterative wild-type p53 gene transfer in human head and neck carcinoma xenografts using glucosylated polyethylenimine nonviral vector. Cancer Gene Ther 2002, 9, 708-714.
9. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, Greenberg ME. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 1997, 275, 661-665.
10. Gauderman WJ, Avol E, Gilliland F, Vora H, Thomas D, Berhane K, McConnell R, Kuenzli N, Lurmann F, Rappaport E, Margolis H, Bates D, Peters J. The effect of air pollution on lung development from 10 to 18 years of age. N Engl J Med 2004, 351, 1057-1067.
11. Gingras AC, Raught B, Sonenberg N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 1999, 68, 913-963.
12. Godbey WT, Wu KK, Hirasaki GJ, Mikos AG. Improved packing of poly(ethylenimine)/DNA complexes increases transfection efficiency. Gene Ther 1999, 6, 1380-1388.
13. Goula D, Becker N, Lemkine GF, Normandie P, Rodrigues J, Mantero S, Levi G, Demeneix BA. Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexes. Gene Ther 2000, 7, 499-504.
14. Griesenbach U, Chonn A, Cassady R, Hannam V, Ackerley C, Post M, Tanswell AK, Olek K, O'Brodovich H, Tsui L-C. Comparison between intratracheal and intravenous administration of liposome-DNA complexes for cystic fibrosis lung gene therapy. Gene Ther 1998, 5, 181-188.
15. Hwang SK, Jin H, Kwon JT, Chang SH, Kim TH, Cho CS, Lee KH, Young MR, Colburn NH, Beck GR Jr, Yang HS, Cho MH. Aerosol-delivered programmed cell death 4 enhanced apoptosis, controlled cell cycle and suppressed AP-1 activity in the lungs of AP-1 luciferase reporter mice. Gene Ther 2007, 14, 1353-1361.
16. Javle MM, Gibbs JF, Iwata KK, Pak Y, Rutledge P, Yu J, Black JD, Tan D, Khoury T. Epithelial-mesenchymal transition (EMT) and activated extracellular signalregulated kinase (p-Erk) in surgically resected pancreatic cancer. Ann Surg Oncol 2007, 14, 3527-3533.
17. S6k. EMBO J 1997, 16, 3693-3704.
18. Kim HW, Park IK, Cho CS, Lee KH, Beck GR Jr, Colburn NH, Cho MH. Aerosol delivery of glucosylated polyethylenimine/phosphatase and tensin homologue deleted on chromosome 10 complex suppresses Akt downstream pathways in the lung of K-ras null mice. Cancer Res 2004, 64, 7971-7976.
19. Lazaris-Karatzas A, Montine KS, Sonenberg N. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap. Nature 1990, 345, 544-547.
20. Lee Y, Cho MY, Mo H, Nam K, Koo H, Jin G, Park JS. Enhancement of the transfection efficiency of poly (ethylenimine) by guanidylation. Bull Korean Chem Soc 2008, 29, 666-668.
21. Leikauf GD. Hazardous air pollutants and asthma. Environ Health Perspect 2002, 110 (Suppl 4), 505-526.
22. Li J, Simpson L, Takahashi M, Miliaresis C, Myers MP, Tonks N, Parsons R. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene. Cancer Res 1998, 58, 5667-5672.
23. Luo J, Manning BD, Cantley LC. Targeting the PI3K-Aktpathway in human cancer: rationale and promise. Cancer Cell 2003, 4, 257-262.
24. Massion PP, Taflan PM, Shyr Y, Rahman SM, Yildiz P, Shakthour B, Edgerton ME, Ninan M, Andersen JJ, Gonzalez AL. Early involvement of the phosphatidylinositol 3-kinase/Akt pathway in lung cancer progression. Am J Respir Crit Care Med 2004, 170, 1088-1094.
25. Merdan T, Kopeček J, Kissel T. Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv Drug Deliv Rev 2002, 54, 715-758.
26. Merlin JL, Dolivet G, Dubessy C, Festor E, Parache RM, Verneuil L, Erbacher P, Behr JP, Guillemin F. Improvement of nonviral p53 gene transfer in human carcinoma cells using glucosylated polyethylenimine derivatives. Cancer Gene Ther 2001, 8, 203-210.
27. Mitsiades CS, Mitsiades N, Koutsilieris M. The Akt pathway: molecular targets for anti-cancer drug development. Curr Cancer Drug Targets 2004, 4, 235-256.
28. Monick MM, Powers LS, Barrett CW, Hinde S, Ashare A, Groskreutz DJ, Nyunoya T, Coleman M, Spitz DR, Hunninghake GW. Constitutive ERK MAPK activity regulates macrophage ATP production and mitochondrial integrity. J Immunol 2008, 180, 7485-7496.
29. Park IK, Cook SE, Kim YK, Kim HW, Cho MH, Jeong HJ, Kim EM, Nah JW, Bom HS, Cho CS. Glucosylated polyethylenimine as a tumor-targeting gene carrier. Arch Pharm Res 2005, 28, 1302-1310.
30. Pfeifer A, Verma IM. Gene therapy: promises and problems. Annu Rev Genomics Hum Genet 2001, 2, 177-211.
31. Plopper CG, Macklin J, Nishio SJ, Hyde DM, Buckpitt AR. Relationship of cytochrome P-450 activity to Clara cell cytotoxicity. III. Morphometric comparison of changes in the epithelial populations of terminal bronchioles and lobar bronchi in mice, hamsters, and rats after parenteral administration of naphthalene. Lab Invest 1992, 67, 553-565.
32. Puchelle E, Zahm JM, Tournier JM, Coraux C. Airway epithelial repair, regeneration, and remodeling after injury in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006, 3, 726-733.
33. Qian J, Zou Y, Rahman JSM, Lu B, Massion PP. Synergy between phosphatidylinositol 3-kinase/Akt pathway and Bcl-xL in the control of apoptosis in adenocarcinoma cells of the lung. Mol Cancer Ther 2009, 8, 101-109.
34. Roux PP, Shahbazian D, Vu H, Holz MK, Cohen MS, Taunton J, Sonenberg N, Blenis J. RAS/ERK Signaling Promotes Site-specific Ribosomal Protein S6 Phosphorylation via RSK and Stimulates Cap-dependent Translation. J Biol Chem 2007, 282, 14056-14064.
35. Ruggero D, Montanaro L, Ma L, Xu W, Londei P, Cordon-Cardo C, Pandolfi PP. The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat Med 2004, 10, 484-486.
36. Ruggero D, Pandolfi PP. Does the ribosome translate cancer? Nat Rev Cancer 2003, 3, 179-192.
37. Ruggero D, Sonenberg N. The Akt of translational control. Oncogene 2005, 24, 7426-7434.
38. Scheper GC, Proud CG. Does phosphorylation of the cap-binding protein eIF4E play a role in translationinitiation? Eur J Biochem 2002, 269, 5350-5359.
39. Shah A, Swain WA, Richardson D, Edwards J, Stewart DJ, Richardson CM, Swinson DEB, Patel D, Jones JL, O'Byrne KJ. Phospho-Akt expression is associated with a favorable outcome in non-small cell lung cancer. Clin Cancer Res 2005, 11, 2930-2936.
40. Staal SP. Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc Natl Acad Sci USA 1987, 84, 5034-5037.
41. Tehrani AM, Hwang SK, Kim TH, Cho CS, Hua J, Nah WS, Kwon JT, Kim JS, Chang SH, Yu KN, Park SJ, Bhandari DR, Lee KH, An GH, Beck GR Jr, Cho MH. Aerosol delivery of Akt controls protein translation in the lungs of dual luciferase reporter mice. Gene Ther 2007, 14, 451-458.
42. Templeton NS, Lasic DD. New directions in liposome gene delivery. Mol Biotechnol 1999, 11, 175-180.
43. Uduehi AN, Stammberger U, Kubisa B, Gugger M, Buehler TA, Schmid RA. Effects of linear polyethylenimine and polyethylenimine/DNA on lung function after airway instillation to rat lungs. Mol Ther 2001, 4, 52-57.
44. Wang L, Proud CG. Ras/Erk signaling is essential for activation of protein synthesis by Gq protein-coupled receptor agonists in adult cardiomyocytes. Circ Res 2002, 91, 821-829.
45. Waskiewicz AJ, Flynn A, Proud CG, Cooper JA. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J 1997, 16, 1909-1920.
46. Wendel HG, De Stanchina E, Fridman JS, Malina A, Ray S, Kogan S, Cordon-Cardo C, Pelletier J, Lowe SW. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 2004, 428, 332-337.
47. Wendel HG, Silva RL, Malina A, Mills JR, Zhu H, Ueda T, Watanabe-Fukunaga R, Fukunaga R, Teruya- Feldstein J, Pelletier J, Lowe SW. Dissecting eIF4E action in tumorigenesis. Genes Dev 2007, 15, 3232-3237.
48. West JA, Buckpitt AR, Plopper CG. Elevated airway GSH resynthesis confers protection to Clara cells from naphthalene injury in mice made tolerant by repeated exposures. J Pharmacol Exp Ther 2000, 294, 516-523.
49. West KA, Brognard J, Clark AS, Linnoila IR, Yang X, Swain SM, Harris C, Belinsky S, Dennis PA. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest 2003, 111, 81-90.
50. Witschi H, Espiritu I, Maronpot RR, Pinkerton KE, Jones AD. The carcinogenic potential of the gas phase of environmental tobacco smoke. Carcinogenesis 1997, 18, 2035-2042.
51. Yildirim AÖ, Veith M, Rausch T, Müller B, Kilb P, Van Winkle LS, Fehrenbach H. Keratinocyte growth factor protects against Clara cell injury induced by naphthalene. Eur Respir J 2008, 32, 694-704.
52. Zaric V, Weltin D, Erbacher P, Remy JS, Behr JP, Stephan D. Effective polyethylenimine-mediated gene transfer into human endothelial cells. J Gene Med 2004, 6, 176-184.